Related Experiment Video
Updated: Apr 23, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
26.0K
Genetic profiling of thymic carcinoma using targeted next-generation sequencing
Masayuki Shitara1, Katsuhiro Okuda1, Ayumi Suzuki1
1Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Lung Cancer (Amsterdam, Netherlands)
|September 25, 2014
Summary
Genetic analysis of thymic carcinoma revealed high mutation heterogeneity. A specific KIT gene mutation was identified as a potential oncogenic driver, offering new insights into thymic cancer development.
Area of Science:
- Oncology
- Genetics
- Genomics
Background:
- Thymic carcinoma is a rare mediastinal neoplasm with poorly understood tumorigenesis.
- Effective treatments are limited, and advanced cases have a poor prognosis.
Purpose of the Study:
- To identify mutations associated with thymic carcinoma tumorigenesis.
- To analyze the genetic profile of thymic carcinoma using targeted next-generation sequencing.
Main Methods:
- Targeted next-generation sequencing of approximately 409 cancer-related genes.
- Analysis of 12 thymic squamous cell carcinoma tissues (10 tumor/normal pairs).
- Mutation filtering using Ingenuity Variant Analysis, SIFT, PolyPhen-2, and PROVEAN.
Main Results:
- Identified 25 candidate mutations across 24 genes, including five tyrosine kinase genes (KIT, DDR2, PDGFRA, ROS1, IGF1R).
- No recurrent mutations were found among the studied samples.
- An activating KIT exon 11 deletion mutation was observed in one patient, suggesting it as a potential oncogenic driver.
Conclusions:
- Genetic profiling reveals significant heterogeneity in thymic squamous cell carcinoma.
- The identified KIT mutation may play a crucial role in thymic cancer development.
- Targeted next-generation sequencing is a viable method for characterizing thymic carcinoma.
